Yano S, Katsuyama Y, Watanabe K
Jpn J Pharmacol. 1986 Oct;42(2):209-16. doi: 10.1254/jjp.42.209.
Gastric transmucosal potential difference (PD) is referred to an index of function and integrity of the mucosa. The features of gastric PD were studied in association with gastric acid secretion. The gastric PD was measured at the forestomach, glandular portion and pylorus in the rat in in situ preparations. Secretagogues such as bethanechol (BeCh, 50 micrograms/kg, i.v.), tetragastrin (TG, 30 micrograms/kg, i.v.), and histamine (Hist, 10 mg/kg, s.c.) produced a decrease in PD at the three regions of the stomach. These PD reductions did not occur with the combined treatment with timoprazole (30 mg/kg, i.d.); a marked increase in PD was noted, especially, in the case of Hist plus timoprazole. Similarly, BeCh induced PD decrease was antagonized by atropine (30 micrograms/kg, i.v.) and Hist induced PD decrease was attenuated by cimetidine (10 mg/kg, i.v.), while TG induced PD decrease was not affected by either of them. Of the antisecretory drugs, only cimetidine produced an increase in basal PD, probably via a mechanism unrelated to acid secretion. These results suggest that the PD decrease by each secretagogue seen at oxyntic and non-oxyntic gland regions of the stomach primarily originates from secretory activation of the parietal cells and that its action on function unrelated to acid secretion also exerts a minor influence on gastric PD.
胃黏膜跨膜电位差(PD)是黏膜功能和完整性的一项指标。研究了胃PD的特征与胃酸分泌的关系。在大鼠原位制备中,测量了前胃、腺部和幽门的胃PD。诸如氨甲酰甲胆碱(BeCh,50微克/千克,静脉注射)、四肽胃泌素(TG,30微克/千克,静脉注射)和组胺(Hist,10毫克/千克,皮下注射)等促分泌剂可使胃的三个区域的PD降低。替莫拉唑(30毫克/千克,十二指肠内注射)联合治疗时未出现这些PD降低情况;尤其是在组胺加替莫拉唑的情况下,PD显著升高。同样,氨甲酰甲胆碱诱导的PD降低被阿托品(30微克/千克,静脉注射)拮抗,组胺诱导的PD降低被西咪替丁(10毫克/千克,静脉注射)减弱,而四肽胃泌素诱导的PD降低不受它们任何一种的影响。在抗分泌药物中,只有西咪替丁可能通过与胃酸分泌无关的机制使基础PD升高。这些结果表明,在胃的泌酸腺区和非泌酸腺区观察到的每种促分泌剂引起的PD降低主要源于壁细胞的分泌激活,并且其对与胃酸分泌无关的功能的作用也对胃PD产生较小影响。